Skip to main content

CaviWipes 2.0

The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of public health crisis. Fully qualifies for the EPA's rigorous Emerging Viral Pathogen Claim.

Features and Benefits

  • Proven effective against SARS-CoV-2 on hard non-porous surfaces
  • EPA List N Compliant
  • Qualifies for the EPA’s Emerging Viral Pathogens claim for all virus types (enveloped, large and small non-enveloped viruses) to meet current and potentially future infection prevention needs
  • Enhanced Efficacy Claims - Effective against over 40 pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections.
  • Excellent Material Compatibilty - Compatible with most non-porous, hard surfaces commonly used in clinical settings
  • Easy to use label - Makes it quick and easy to find critical information on efficacy, compatibility, and more
  • 2-minute universal contact time for bacteria, viruses, and pathogenic fungi (Candida auris)

Kill Claims

2 Minute Efficacy Against

Mycobacterium Bacteria
  • Mycobacterium tuberculosis (TB)
Non-Enveloped Viruses
  • Adenovirus Type 2
  • Echovirus Type 11
  • Enterovirus Type 71
  • Human Rotavirus
  • Norovirus
  • Feline Calicivirus
Pathogenic Fungi
  • Candida auris
Multi Drug-Resistant Bacteria
  • Carbapenem-resistant Klebsiella pneumoniae (CRKP)
  • Methicillin-Resistant Staphylococcus aureus (MRSA)
  • Multidrug-Resistant Acinetobacter baumannii (MRAB)
  • NDM-1 Enterobacter cloacae
  • Penicillin-Resistant Streptococcus pneumoniae (PRSP)
  • Vancomycin-Intermediate Staphylococcus aureus (VISA)
  • Vancomycin-Resistant Enterococcus faecalis (VRE)
  • Acinetobacter baumannii
  • Bordetella pertussis
  • Burkholderia cepacia
  • Enterococcus faecium
  • Escherichia coli O157:H7
  • Klebsiella pneumoniae
  • Legionella pneumophila
  • Micrococcus luteus
  • Moraxella catarrhalis
  • Pseudomonas aeruginosa
  • Salmonella enterica
  • Staphylococcus aureus
  • Stenotrophomonas maltophilia
  • Streptococcus mutans
  • Streptococcus pyogenes
Enveloped Viruses
  • Hepatitis B Virus (HBV)
  • Hepatitis C Virus (HCV)
  • Herpes simplex virus Type 1
  • Herpes simplex virus Type 2
  • Human lmmunodeficiency Virus Type 1 (HIV-1)
  • Human orthopneumovirus
  • lnfluenza A virus
  • lnfluenza B virus
  • Measles virus
  • Parainfluenza virus Type 3
  • SARS-Associated Coronavirus
  • SARS-CoV-2

Ordering Information

CaviWipes 2.0 (6" x 6.75") - 160 Wipes per Canister, 12 Canisters/Case

SKU 14-1100

CaviWipes 2.0 XL (9" x 12") - 160 Towelettes per Canister, 12 Canisters/Case

SKU 14-1150

Wipe Wall Bracket - 12 Brackets/Case

SKU 13-1175


Click here to see all product related information and resources.

Safety Data Sheets (SDS)

CaviWipes 2.0 US SDS

White Paper

CaviWipes 2.0 White Paper

Technical Document

CaviWipes 2.0 Technical Bulletin

Product Brochure

Surface Disinfectant Brochure

Sales Sheet

CaviWipes 2.0 Sales Sheet

Related Products

  • CaviCide1™

    Fast and effective one step cleaner and disinfectant available in multiple configurations to help reduce the risk of cross-contamination with a 1 minute contact time.

  • CaviWipes™ Bleach

    Demonstrates effectiveness against over 40 relevant microorganisms. 1:10 Bleach dilution. No PPE required.

  • CaviWipes™

    3 Minute cleaner and disinfectant. Made of durable non-woven towelettes that offer quick easy-to-use convenience.